Trial intelligence / Profile preview

Subanesthetic esketamine with intravenous general anesthesia for pediatric bronchoscopy

ChiCTR2100053302Phase 4Recruiting

Sponsor
The First Affiliated Hospital of Guangxi Medical University
Start
Nov 2021
Modality
Small Molecules
Countries
1
01

Overview

Phase 4 trial of esketamine in bronchopulmonary diseases (2 arms), sponsored by The First Affiliated Hospital of Guangxi Medical University. Primary endpoints: Hemodynamic changes, Induction quality and 1 more. Started Nov 2021; status: recruiting.

02

Drugs

esketamine
03

Conditions

bronchopulmonary diseases

Beyond the preview

Go deeper on ChiCTR2100053302.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2100053302.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call